-
Product Insights
Rheumatoid Arthritis - Global Clinical Trials Review, 2026
Understand the Global Clinical Trials Landscape for Rheumatoid Arthritis Rheumatoid arthritis remains a key focus area in global clinical research, with ongoing trials shaping the future of treatment and innovation. This report provides a comprehensive snapshot of the global clinical trials landscape, covering trial activity across regions, countries (G7 & E7), phases, statuses, endpoints, and sponsor types. As a result, you gain a clear understanding of where research is accelerating and how the competitive landscape is evolving. Report Value Proposition...
-
Product Insights
Juvenile Rheumatoid Arthritis - Drugs In Development, 2024
Empower your strategies with our Juvenile Rheumatoid Arthritis – Drugs In Development, 2024 report and make more profitable business decisions. Juvenile idiopathic arthritis (JIA) is the most common type of arthritis in kids and teens. It typically causes joint pain and inflammation in the hands, knees, ankles, elbows and/or wrists. But, it may affect other body parts too . JIA used to be called juvenile rheumatoid arthritis (JRA), but the name changed because it is not a kid version of the...
-
Thematic Analysis
Cell and Gene Therapies in Rheumatology - Disease Overview, Treatment Options and Future Market Assessment
Cell and Gene Therapies in Rheumatology Market Report Overview The market size for cell and gene therapies (CGT) in rheumatic diseases by molecule type is estimated to be $24 million in 2024. Cell therapies will continue to dominate the CGT market in rheumatic diseases. This growth is attributed to the high number of cell therapy assets in the pipeline and increasing interest in rheumatic diseases due to the increasing prevalence and high unmet need, especially as the aging population increases....
-
Thematic Analysis
Digital Marketing Trends in Rheumatoid Arthritis
Digital Marketing Trends in Rheumatoid Arthritis Report Overview AbbVie’s Rinvoq.com achieved the highest total traffic across Rheumatoid Arthritis (RA) patient sites in the US, from February 2023 to January 2024. This was followed by AbbVie’s Humira.com. Overall, the highest proportion of traffic to top branded patient RA websites originated from direct sources, followed by organic. Buy the Full Report to get More Insights into the Digital Marketing Trends in Rheumatoid Arthritis Download a Free Report Sample The ‘Digital Marketing Trends...
-
Sector Analysis
Rheumatoid Arthritis (RA) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Reasons to buy the ‘Rheumatoid Arthritis (RA)’ marketed and pipeline drugs assessment report: Get a comprehensive overview of the rheumatoid arthritis market including disease epidemiology, treatment guidelines, clinical trials, deals, and an assessment of marketed and pipeline drugs. Get an insight into MoA, RoA, and molecule types for the leading marketed and pipeline drugs in RA. Assess the pricing and reimbursement of rheumatoid arthritis marketed and pipeline drugs. Get a detailed assessment of the clinical trials taking place within the...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.